Gyros Expands Asian Distribution to Singapore.

Gyros AB, a leader in utilisation of microfluidic technologies to miniaturise and automate immunoassays, has appointed Bio Laboratories Pte Ltd as sole distributor for the company’s nanoliter-scale immunoassay platform in Singapore.

“We are very pleased to expand our reach in Asia through this new partnership with Bio Laboratories, which provides a valuable addition to our recently announced collaboration with GE Healthcare for distribution in Japan, China, Taiwan and Hong Kong,” commented Erik Walldén, CEO, Gyros. “As our immunoassay platform increases in acceptance within the biopharmaceutical industry, it is ever more vital that we have an experienced and respected network of distributors to ensure the highest possible standards of service and support for our customers.”

Benny Wee, Managing Director, Bio Laboratories, said, “The Gyros immunoassay platform is an excellent addition to our extensive range of distribution agreements with high quality, innovative analytical instrument providers. We are delighted to be able to now offer Gyros’ products to the biopharmaceutical industry in Singapore.”